134 related articles for article (PubMed ID: 26985948)
1. Correlation analysis between an IL-6 genetic polymorphism and non-small cell lung cancer prognosis.
Zhao K; Xu J; Tian H
Genet Mol Res; 2016 Mar; 15(1):15017021. PubMed ID: 26985948
[TBL] [Abstract][Full Text] [Related]
2. IL-6 polymorphism in non-small cell lung cancer: a prognostic value?
Gomes M; Coelho A; Araújo A; Azevedo A; Teixeira AL; Catarino R; Medeiros R
Tumour Biol; 2015 May; 36(5):3679-84. PubMed ID: 25566963
[TBL] [Abstract][Full Text] [Related]
3. A study on the effect of IL-6 gene polymorphism on the prognosis of non-small-cell lung cancer.
Jia W; Fei GH; Hu JG; Hu XW
Onco Targets Ther; 2015; 8():2699-704. PubMed ID: 26445552
[TBL] [Abstract][Full Text] [Related]
4. The influence of tumor necrosis factor-alpha -308 G/A and IL-6 -174 G/C on pain and analgesia response in lung cancer patients receiving supportive care.
Reyes-Gibby CC; El Osta B; Spitz MR; Parsons H; Kurzrock R; Wu X; Shete S; Bruera E
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3262-7. PubMed ID: 18990769
[TBL] [Abstract][Full Text] [Related]
5. Significant impact of IL-6 -174G/C but inverse relation with -634 C/G polymorphism in patients with non-small cell lung cancer in Kashmiri population.
Bhat IA; Qasim I; Masoodi KZ; Paul SA; Bhat BA; Rasool R; Aziz SA; Shah ZA
Immunol Invest; 2015; 44(4):349-60. PubMed ID: 25942346
[TBL] [Abstract][Full Text] [Related]
6. Strong association of interleukin-6 -174G/C promoter single nucleotide polymorphism with a decreased risk of colorectal cancer in ethnic Kashmiri population: A case control study.
Banday MZ; Balkhi HM; Sameer AS; Chowdri NA; Haq E
Tumour Biol; 2017 Mar; 39(3):1010428317695940. PubMed ID: 28349833
[TBL] [Abstract][Full Text] [Related]
7. Influence of functional genetic polymorphism (-590C/T) in non-small cell lung cancer (NSCLC) development: the paradoxal role of IL-4.
Gomes M; Coelho A; Araújo A; Teixeira AL; Catarino R; Medeiros R
Gene; 2012 Aug; 504(1):111-5. PubMed ID: 22583827
[TBL] [Abstract][Full Text] [Related]
8. Association of IL-8 gene polymorphisms with non small cell lung cancer in Tunisia: A case control study.
Rafrafi A; Chahed B; Kaabachi S; Kaabachi W; Maalmi H; Hamzaoui K; Sassi FH
Hum Immunol; 2013 Oct; 74(10):1368-74. PubMed ID: 23831257
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer.
Zhai K; Yang Y; Gao ZG; Ding J
Oncotarget; 2017 Jul; 8(27):44490-44497. PubMed ID: 28548958
[TBL] [Abstract][Full Text] [Related]
10. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Hsu WF; Chen WE; Chou MC; Lin LY
Lung Cancer; 2005 Dec; 50(3):291-7. PubMed ID: 16122836
[TBL] [Abstract][Full Text] [Related]
11. Lack of association between IL-6 -174G>C polymorphism and lung cancer: a meta-analysis.
Liu Y; Song XL; Zhang GL; Peng AM; Fu PF; Li P; Tan M; Li X; Li M; Wang CH
Genet Mol Res; 2015 Jan; 14(1):163-9. PubMed ID: 25729947
[TBL] [Abstract][Full Text] [Related]
12. Relationship between single nucleotide polymorphisms in -174G/C and -634C/G promoter region of interleukin-6 and prostate cancer.
Bao S; Yang W; Zhou S; Ye Z
J Huazhong Univ Sci Technolog Med Sci; 2008 Dec; 28(6):693-6. PubMed ID: 19107369
[TBL] [Abstract][Full Text] [Related]
13. Cytokine genes and pain severity in lung cancer: exploring the influence of TNF-alpha-308 G/A IL6-174G/C and IL8-251T/A.
Reyes-Gibby CC; Spitz M; Wu X; Merriman K; Etzel C; Bruera E; Kurzrock R; Shete S
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2745-51. PubMed ID: 18086782
[TBL] [Abstract][Full Text] [Related]
14. Effects of interleukin (IL)-6 gene polymorphisms on recurrent aphthous stomatitis.
Karakus N; Yigit S; Rustemoglu A; Kalkan G; Bozkurt N
Arch Dermatol Res; 2014 Mar; 306(2):173-80. PubMed ID: 23982631
[TBL] [Abstract][Full Text] [Related]
15. The Effectiveness of Pemetrexed Monotherapy Depending on Polymorphisms in TS and MTHFR Genes as Well as Clinical Factors in Advanced NSCLC Patients.
Kucharczyk T; Krawczyk P; Powrózek T; Kowalski DM; Ramlau R; Kalinka-Warzocha E; Knetki-Wróblewska M; Winiarczyk K; Krzakowski M; Milanowski J
Pathol Oncol Res; 2016 Jan; 22(1):49-56. PubMed ID: 26277606
[TBL] [Abstract][Full Text] [Related]
16. Lack of relationship between 174G_C promoter polymorphism of the IL-6 gene and indices of metabolic syndrome in non-obese healthy subjects.
Tworowska-Bardzińska U; Kubicka E; Slezak R; Mielcarek M; Bednarek-Tupikowska G; Bolanowski M; Milewicz A
Endokrynol Pol; 2009; 60(3):172-9. PubMed ID: 19569017
[TBL] [Abstract][Full Text] [Related]
17. Associations of MDM2 SNP309, transcriptional activity, mRNA expression, and survival in stage I non-small-cell lung cancer patients with wild-type p53 tumors.
Chien WP; Wong RH; Cheng YW; Chen CY; Lee H
Ann Surg Oncol; 2010 Apr; 17(4):1194-202. PubMed ID: 19941079
[TBL] [Abstract][Full Text] [Related]
18. The increased plasma C-reactive protein and interleukin-6 levels in patients undergoing coronary artery bypass grafting surgery are associated with the interleukin-6-174G > C gene polymorphism.
Wypasek E; Undas A; Sniezek-Maciejewska M; Kapelak B; Plicner D; Stepien E; Sadowski J
Ann Clin Biochem; 2010 Jul; 47(Pt 4):343-9. PubMed ID: 20592333
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.
DeMichele A; Martin AM; Mick R; Gor P; Wray L; Klein-Cabral M; Athanasiadis G; Colligan T; Stadtmauer E; Weber B
Cancer Res; 2003 Nov; 63(22):8051-6. PubMed ID: 14633738
[TBL] [Abstract][Full Text] [Related]
20. The association of the 174G>C polymorphism of interleukin 6 gene with diabetic nephropathy in patients with type 2 diabetes mellitus.
Papaoikonomou S; Tentolouris N; Tousoulis D; Papadodiannis D; Miliou A; Papageorgiou N; Hatzis G; Stefanadis C
J Diabetes Complications; 2013; 27(6):576-9. PubMed ID: 23871133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
